Patients For Affordable Drugs NOW

P4ADNow is a bipartisan patient advocacy organization fighting for lower drug prices. We mobilize patients in support of legislation to fix our broken system.

[Patients For Affordable Drugs NOW @P4ADNOW]

NEW VIDEO: We just released a new video explaining one of the most important — and least talked about — drivers of high drug prices: patent abuse. The ETHIC Act would close the loopholes drug companies exploit to block cheaper generics. Watch, share, and urge Congress to act: https://t.co/CRR9ojek4E

[Patients For Affordable Drugs NOW @P4ADNOW]

P4AD released a new video, prescription drug prices fell 3.1% over the past year, the D.C. Court of Appeals rejected Teva’s core challenges to Medicare drug price negotiation, and the pharmaceutical industry continues to generate enormous revenue while millions of patients ration medications. Read more at our Week in Review: https://t.co/MOvRK1IWzE

Get the latest updates on drug pricing reforms and patient advocacy efforts from Patients For Affordable Drugs NOW delivered straight to your inbox! Subscribe here: https://t.co/rteVwsZcxi

[Emma Sands @EmmaSands_]

Pharma patent abuse is getting the national attention it deserves. @EpochTimes just published a deep dive on how drug companies stack overlapping patents to keep prices high - featuring P4AD advocates living with the consequences every day.

Read it here: https://t.co/R3tenqdDOc

[Patients For Affordable Drugs NOW @P4ADNOW]

The ETHIC Act would reduce drug company patent abuse and lower drug prices for patients by addressing double patenting but Big Pharma's lobbyists are hard at work against it.

Fight back against Big Pharma greed! Watch, share, and urge Congress to act: https://t.co/BrksRVoSkV

[Patients For Affordable Drugs NOW @P4ADNOW]

Kris Garcia, un Defensor de Pacientes de P4AD, paga $10,000 al mes por sus medicamentos. Debibo a esto, Kris ha tenido que tomar decisiones muy dificiles para asegurarse de que pueda seguir sano. Si tu o alguien que conoces tiene una historia personal con el alto costo de los medicamentos recetados, comparte tu historia con P4AD: https://t.co/RjHDDMdddf

[Patients For Affordable Drugs NOW @P4ADNOW]

Six months after TrumpRx launched and we have a clearer picture of who it helps and its limitations, P4AD participated in the Latino Health Summit, and the fourth anniversary of the IRA. Read more at our Week in Review: https://t.co/SJ1jtsQktI

Get the latest updates on drug pricing reforms and patient advocacy efforts from Patients For Affordable Drugs NOW delivered straight to your inbox! Subscribe here: https://t.co/rteVwsZcxi

[Patients For Affordable Drugs NOW @P4ADNOW]

The ETHIC Act would reduce drug company patent abuse by addressing double patenting but Big Pharma's lobbyists are hard at work against it.

Fight back against Big Pharma greed! Watch, share, and urge Congress to act: https://t.co/BrksRVoSkV

[Patients For Affordable Drugs NOW @P4ADNOW]

Closed-Door Policy Change Exempted Blockbuster AbbVie Drug from Negotiations, Most-Favored-Nation Pricing Could Save Medicare Nearly $200 Billion, and New Analysis Confirms: ORPHAN Cures is an Unnecessary Pharma Giveaway. Read more at our Week in Review: https://t.co/WvCaydHc4W

Get the latest updates on drug pricing reforms and patient advocacy efforts from Patients For Affordable Drugs NOW delivered straight to your inbox! Subscribe here: https://t.co/rteVwsZcxi

[Patients For Affordable Drugs NOW @P4ADNOW]

What's one of the most important — and least talked about — drivers of high drug prices? 🤔

Drug company patent abuse.

The ETHIC Act would close the loopholes drug companies exploit to block cheaper generics. Watch, share, and urge Congress to act: https://t.co/BrksRVoSkV

[Patients For Affordable Drugs NOW @P4ADNOW]

Las farmacéuticas de marca están manipulando el sistema de patentes para mantener altos los precios de los medicamentos, y los pacientes están enfrentando dificultades. Aprende más sobre el _product hopping_ y otras prácticas de la gran industria farmacéutica en https://t.co/4hOgYgxi0M en el enlace de nuestra biografía.

[Patients For Affordable Drugs NOW @P4ADNOW]

🆕 FROM P4AD
👀 8.19.26. 👀

[Patients For Affordable Drugs NOW @P4ADNOW]

Use your voice to help change policy! Share your story with P4ADNOW: https://t.co/MUix7rpW7B

¡Usa tu voz para cambiar las políticas! Comparte tu historia con P4ADNOW: https://t.co/dX2vigKYzi

[Patients For Affordable Drugs NOW @P4ADNOW]

Xeljanz and Xeljanz XR will be removed from negotiations in 2029, President Trump is ending Medicare drug premium subsidies, and tariffs on patented drugs and their ingredients took effect today. Read more at our Week in Review: https://t.co/yemfai3E7U

Get the latest updates on drug pricing reforms and patient advocacy efforts from Patients For Affordable Drugs NOW delivered straight to your inbox! Subscribe here: https://t.co/rteVwsZcxi

[Patients For Affordable Drugs NOW @P4ADNOW]

Drug companies have spent millions pushing the narrative that middlemen like PBMs are the primary driver of high drug prices. That messaging push has gained traction, and PBMs are responding with increased advocacy of their own. While PBMs’ opaque and profit-driven practices play a significant role in patients’ access and costs, drug prices are ultimately set by manufacturers. The result is a system where powerful industry players continue to shift blame, while patients face the consequences of high and rising prices. Meaningful reform will require addressing the full system — starting with the pricing power of drug companies — to deliver lower costs for patients.

[Patients For Affordable Drugs NOW @P4ADNOW]

Pharmaceutical corporations remain the biggest driver of high drug prices. Drug companies set prices at launch, raise them over time, and abuse the patent system to block lower-cost competition. To meaningfully lower costs for patients and taxpayers, we must address these practices while eliminating the perverse incentives that allow PBMs to profit from higher-priced drugs. Patients shouldn't be paying more while the prescription drug supply chain rewards drugmakers for keeping prices as high as possible. Learn how P4ADNOW's growing community of patient advocates is taking action against drug company greed at https://t.co/NUDyltrBou.

[Patients For Affordable Drugs NOW @P4ADNOW]

Your Voice Is Your Power.
👀 8.19.26. 👀

[Patients For Affordable Drugs NOW @P4ADNOW]

Polling from @KFF reveals about 43% of adults in the US have skipped, rationed, or gone without a prescription drug due to cost in the past year. At Patients For Affordable Drugs, we believe that no one should have to make the impossible choice between the medications they need to live and other bills. Visit https://t.co/WNxaz1SlIo to learn more and join the fight for lower prescription drug prices.

[Patients For Affordable Drugs NOW @P4ADNOW]

The ETHIC Act would reduce drug company patent abuse by addressing double patenting but Big Pharma's lobbyists are hard at work against it.

Fight back against Big Pharma greed! Watch, share, and urge Congress to act: https://t.co/BrksRVoSkV

[Patients For Affordable Drugs NOW @P4ADNOW]

As debate continues around new proposals to lower prescription drug prices for Americans, one thing is clear: the 2022 prescription drug law is already helping to lower costs for millions of patients across the country.

As of January 1, 2026, all major provisions of the law are in effect. What began as a series of phased-in reforms has lowered out-of-pocket costs, improved access, and brought greater predictability to millions of Americans.

As policymakers look ahead at a time when nine in ten Americans are calling on Congress to do more to lower prescription drug costs, these real-world impacts underscore the importance of building on what’s working and addressing the remaining barriers that keep patients from accessing and affording the medications they need.

[Patients For Affordable Drugs NOW @P4ADNOW]

House E&C and Senate HELP advanced three bipartisan P4ADNow-backed drug pricing bills, mid-year lobbying disclosures show the pharmaceutical industry once again dominating Washington, and President Trump announced a 100% tariff on generic drugs starting in August 2028. Read more at our Week in Review: https://t.co/dFLfmbZyd7

Get the latest updates on drug pricing reforms and patient advocacy efforts from Patients For Affordable Drugs NOW delivered straight to your inbox! Subscribe here: https://t.co/rteVwsZcxi

[Patients For Affordable Drugs NOW @P4ADNOW]

When Big Pharma games the patent system, patients pay the price. But there are bipartisan bills in Congress that are smart, practical steps to take on Big Pharma's patent abuse strategies and would bring lower cost competition to market faster. Visit https://t.co/pivD3OAYX6 to learn more and get involved.